Alliances

Veritas has established an exclusive partner alliance and investment in Cannevert Therapeutics, a high-level research & development company, with the main office on the University of British Columbia (UBC) campus. Cannevert has brought together a team of pharmacologists, anesthetists, and chemists with substantial prior success in drug development in both academia and industry. This alliance will provide Veritas with the needed technical ability to achieve its vision in terms of research, development & commercialization goals.

Untitled-1

Cannevert Therapeutics Ltd.

Veritas has established an exclusive partner alliance and investment in Cannevert Therapeutics, a high-level research & development company, with facilities at the University of British Columbia (UBC). Bringing together a highly accredited team of pharmacologists, anesthetists, and chemists with substantial prior success in both academia and industry, specifically in drug development. This alliance will provide Veritas with the needed technical ability to deliver on its research, development & commercialization goals.

On December 18, 2015, Veritas entered into a Share Purchase Agreement with Cannevert Therapeutics Ltd., a group of academics at The University of British Columbia. Under the terms of the agreement, Veritas will contribute $1.5m over the next 18 months through $250K quarterly installments. After this period, Veritas will own 80% of Cannevert. The balance of Cannevert will be acquired with Veritas shares based on independent valuation of Cannevert.

WMM-logo

Whistler Medical Marijuana Corporation

Whistler Medical Marijuana Corp. is a Health Canada licensed producer of certified organic medical marijuana.

Veritas Pharma Inc. formed a strategic alliance with Whistler Medical Marijuana Corporation whereby Whistler will be the principal supplier of varied marijuana cultivars for Cannevert Therapeutics over the next 18 months. Whistler is licensed by Health Canada to produce dried or fresh marijuana as well as cannabis oil. Veritas will purchase this material from Whistler and supply it to Cannevert for research purposes. Representatives of Whistler will sit on the Veritas Advisory Board.

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!